Market Place
Sourcing Support
Clinigen launches NaviGATE: an educational programme for rare disease patients
12 Sep 2023 //
GLOBENEWSWIRE
Clinigen divests rights to four cancer support therapies to CNX Therapeutics
10 Aug 2023 //
GLOBENEWSWIRE
Adragos Pharma Acquires Clinigen`s Development Unit, Lamda Laboratories
27 Mar 2023 //
CONTRACT PHARMA
Clinigen divests Proleukin® to Iovance Biotherapeutics for £166.7 million
23 Jan 2023 //
GLOBENEWSWIRE
Clinigen adds pharmacovigilance capabilities with acquisition of Navigator
29 Nov 2022 //
GLOBENEWSWIRE
UK recall of Clinigen’s Mexiletine hydrochloride hard capsules
05 Aug 2022 //
EUROPEAN PHARMACEUTICAL REVIEW
Clinigen expands US site capacity for Clinical Supplies Management services
24 May 2022 //
GLOBENEWSWIRE
Clinigen and Deciphera ink distribution deal for GIST drug
10 Feb 2022 //
THEPHARMALETTER
Humanigen Launches Managed Access Program for Lenzilumab
09 Feb 2022 //
BUSINESSWIRE
UK`s Clinigen agrees to sweetened $1.8 billion Triton take-private deal
18 Jan 2022 //
REUTERS
Cancer drug specialist Clinigen strikes £1.2-billion deal to go private
08 Dec 2021 //
THEGUARDIAN
Clinigen confirms takeover talks with Triton, shares surge
02 Dec 2021 //
ISE
Humanigen Signs Contract With Clinigen for Lenzilumab Managed Access Program
08 Oct 2021 //
BUSINESSWIRE
Clinigen Signs Exclusive UK Supply and Distribution Agreement with Paion
02 Sep 2021 //
PRESS RELEASE
Clinigen signs exclusive agreement with Eyevance Pharmaceuticals
05 Aug 2021 //
INVESTEGATE3
Clinigen Expands Partnership With Accord Healthcare in Clinical Into France
24 Nov 2020 //
BUSINESSWIRE
Clinigen`s ALS therapy bags US orphan status
13 Jul 2020 //
PHARMATIMES
Xeris Signs Exclusive Agreement With Clinigen to Supply and Distribute Gvoke™
14 May 2020 //
BUSINESSWIRE
Clinigen signs agreement with Iovance Biotherapeutics
14 Jan 2020 //
PRESS RELEASE
Clinigen launches programme to provide Azedra outside US
18 Oct 2019 //
PHARMATIMES
Clinigen launches Managed Access Program for Progenics Pharma
14 Oct 2019 //
PHARMABIZ
Clinigen Signs Exclusive Distribution Agreement with CHEPLAPHARM Etopophos®
02 Sep 2019 //
BUSINESSWIRE
Clinigen completes acquisition of US rights to Proleukin
02 Apr 2019 //
BIOSPACE
Clinigen buys U.S. rights to Novartis` cancer drug Proleukin
13 Feb 2019 //
REUTERS
Clinigen acquires unlicensed medicines supplier in Japan
25 Oct 2017 //
OUTSOURCING
Clinigen and Quantum Pharma offer lesson to entrepreneurs
18 Sep 2017 //
FT
Clinigen boost unlicensed drugs business with Quantum takeover
13 Sep 2017 //
REUTERS
Quantum Pharma confirms Clinigen takeover bid
17 Aug 2017 //
PMLIVE
Clinigen partners with Tesaro’s PARP med for European preapproval access
13 May 2017 //
FIERCE BIOTECH
Clinigen makes foray into Japan
18 Oct 2016 //
BIO SPECTRUM
Cumberland Pharma & Clinigen Group enter into exclusive US commercial agreement
10 May 2016 //
PR NEWSWIRE
Clinigen Broadens Global Footprint with Deal Worth $155 Million
22 Sep 2015 //
BIOSPACE
Clinigen and Cumberland collaborate in mutual market access deal
17 Sep 2015 //
IN-PHARMA TECHNOLOGIST
